IDEAYA Biosciences, Inc. (IDYA)
26.49
-0.91
(-3.32%)
USD |
NASDAQ |
Nov 18, 16:00
26.50
+0.01
(+0.04%)
After-Hours: 20:00
IDEAYA Biosciences Enterprise Value : 1.751B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.751B |
| November 17, 2026 | 1.839B |
| November 16, 2026 | 2.125B |
| November 13, 2026 | 2.268B |
| November 12, 2026 | 2.235B |
| November 11, 2026 | 2.353B |
| November 10, 2026 | 2.260B |
| November 09, 2026 | 2.287B |
| November 06, 2026 | 2.211B |
| November 05, 2026 | 2.153B |
| November 04, 2026 | 2.319B |
| November 03, 2026 | 2.219B |
| November 02, 2026 | 2.249B |
| October 30, 2026 | 2.280B |
| October 29, 2026 | 2.370B |
| October 28, 2026 | 2.473B |
| October 27, 2026 | 2.429B |
| October 26, 2026 | 2.369B |
| October 23, 2026 | 2.546B |
| October 22, 2026 | 2.682B |
| October 21, 2026 | 2.619B |
| October 20, 2026 | 2.609B |
| October 19, 2026 | 2.459B |
| October 16, 2026 | 2.366B |
| October 15, 2026 | 2.463B |
| Date | Value |
|---|---|
| October 14, 2026 | 2.464B |
| October 13, 2026 | 2.502B |
| October 12, 2026 | 2.676B |
| October 09, 2026 | 2.681B |
| October 08, 2026 | 2.676B |
| October 07, 2026 | 2.696B |
| October 06, 2026 | 2.731B |
| October 05, 2026 | 2.870B |
| October 02, 2026 | 2.802B |
| October 01, 2026 | 2.845B |
| September 30, 2026 | 2.904B |
| September 29, 2026 | 2.849B |
| September 28, 2026 | 2.884B |
| September 25, 2026 | 2.736B |
| September 24, 2026 | 2.741B |
| September 23, 2026 | 2.811B |
| September 22, 2026 | 3.027B |
| September 21, 2026 | 2.946B |
| September 18, 2026 | 2.902B |
| September 17, 2026 | 2.921B |
| September 16, 2026 | 2.837B |
| September 15, 2026 | 2.830B |
| September 14, 2026 | 2.866B |
| September 11, 2026 | 2.823B |
| September 10, 2026 | 2.810B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 1.041B |
| Xencor, Inc. | 2.326B |
| ACADIA Pharmaceuticals, Inc. | 2.176B |
| Arrowhead Pharmaceuticals, Inc. | 6.299B |
| BioMarin Pharmaceutical, Inc. | 15.37B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -125.75M |
| Revenue (Quarterly) | 10.24M |
| Total Expenses (Quarterly) | 135.99M |
| EPS Diluted (Quarterly) | -1.222 |
| Gross Profit Margin (Quarterly) | 89.93% |
| Profit Margin (Quarterly) | -1.23K% |
| Earnings Yield | -16.96% |
| Normalized Earnings Yield | -16.96 |